Pharmaceutical growth seen slowing in first quarter

Published: 2007-02-12 07:00:00

Updated: 2007-02-12 07:00:00

Leading pharmaceutical firms' growth in sales is expected to slow further in the first quarter of this year on sluggish domestic demand for prescription drugs, pharmaceutical business sources said.

The downturn of the pharmaceutical business will be mainly caused by weaker demand and more heat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK